Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTclarke Regulatory News (CTO)

Share Price Information for Tclarke (CTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 161.00
Bid: 161.00
Ask: 162.00
Change: 0.25 (0.16%)
Spread: 1.00 (0.621%)
Open: 161.00
High: 162.00
Low: 161.00
Prev. Close: 161.25
CTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

9 Oct 2015 15:04

RNS Number : 8531B
Clarke(T.) PLC
09 October 2015
 

T.CLARKE PLC(the "Company")

SAVINGS RELATED SHARE OPTION SCHEME - GRANT OF OPTIONS

 

On 9th October 2015, the Directors of the Company were granted options over ordinary shares of 10p each in the capital of the Company ("Shares") under the T.Clarke plc Savings Related Share Option Scheme ("the Scheme"). 

Details of the directors and the number of shares over which options were granted to them under the Scheme are as follows:

Director

Number of share options

Exercise price of options

Mark Lawrence

10,322

69.75p /share

Mike Crowder

10,322

69.75p /share

Martin Walton

10,322

69.75p /share

The above represents the maximum number of options available to the directors under the rules of the Scheme. No consideration was paid for the grant of the options.

The Scheme was formally launched for 2015 on 9th September 2015 and was made available to all eligible employees. The options have an exercise price of 69.75 pence per share which represents a discount of 10% to the market price at close on 8th September 2015, being the day preceding the Scheme launch.

Options may normally be exercised during the six months following the Maturity Date at the end of the three-year savings period. The Maturity Date is 30 November 2018. A total of 1,744,284 shares are under option for the Scheme.

Following the grant of the options under the Scheme the Executive Directors hold the following beneficial interests in the issued share capital of the Company:

Director

Beneficial Interest in the Shares of the Company

% of the Issued Share Capital of the Company

Number of Conditional Share Awards Held Under the LTIP Scheme

Total No. Options Under the LTIP Scheme

Total Number of Shares Under SAYE Scheme Option

Mark Lawrence

26,750

0.05%

290,000

59,000

24,845

Mike Crowder

18,750

0.03%

290,000

59,000

24,845

Martin Walton

16,750

0.02%

290,000

59,000

24,845

Danny Robson

1,451,906

3.47%

90,000

Nil

Nil

For further information contact:

TClarke plc

Mark Lawrence, Group Chief Executive

Martin Walton, Finance DirectorAlexandra Dent, Company Secretary

Tel: 020 7997 7400

www.tclarke.co.uk

 

N+1 Singer (Financial Adviser and Broker)

Sandy Fraser, Partner

Tel: 020 7496 3000

www.n1singer.com

 

Broker Profile

Simon Courtenay

Harry Rippon

Tel: 020 7448 3244

www.broker-profile.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSMLBITMBMMBMA
Date   Source Headline
25th Apr 20241:56 pmPRNForm 8.3 - TClarke Plc
25th Apr 202411:52 amRNSForm 8.3 - TClarke PLC
25th Apr 20249:18 amRNSForm 8 (OPD) - TClarke plc
24th Apr 20247:21 amRNSForm 8.5 (EPT/NON-RI)
22nd Apr 20242:58 pmPRNForm 8.3 - TClarke Plc
19th Apr 20241:21 pmPRNForm 8.3 - TClarke Plc
18th Apr 20243:29 pmRNSForm 8.3 - TClarke plc
18th Apr 20247:00 amRNSForm 8.1: Regent Acquisitions Limited
17th Apr 20243:29 pmRNSForm 8.3 - TClarke plc
17th Apr 20243:03 pmGNWForm 8.3 - [TCLARKE PLC - 16 04 2024] - (CGAML)
17th Apr 202412:57 pmEQSForm 8.3 - Apex Fundrock Limited : Form 8.3 - Opening Position Disclosure Re: Clarke (T.) PLC
17th Apr 20249:47 amRNSForm 8.5 (EPT/NON-RI)
16th Apr 20244:36 pmRNSWider Regent Group Interests in TClarke Shares
16th Apr 20247:00 amRNSRevised Dividend Timetable
16th Apr 20247:00 amRNSRecommended Cash Acquisition of TClarke plc
9th Apr 20241:41 pmRNSDirector/PDMR Shareholding
2nd Apr 20241:34 pmRNSTR-1 Notification of Holdings
27th Mar 20242:00 pmRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSFinal Results
4th Jan 20247:00 amRNSBlock listing Interim Review
30th Nov 20237:00 amRNSTrading Update
24th Oct 202310:21 amRNSChange of Corporate Broker
27th Jul 20234:24 pmRNSTR-1: Notification of Change of Holding
24th Jul 20235:43 pmRNSUpdate on Admission
24th Jul 20233:32 pmRNSTR-1: Notification of Change of Holding
24th Jul 202311:48 amRNSResult of GM & Total Voting Rights
13th Jul 20231:23 pmRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSHalf-year Report
6th Jul 20237:00 amRNSPlacing and Notice of GM
6th Jul 20237:00 amRNSTrading Statement
4th Jul 20237:00 amRNSBlock listing Interim Review
10th May 202311:31 amRNSResult of AGM
10th May 20237:00 amRNSAGM Trading Update
12th Apr 202311:15 amRNSNotice of AGM
27th Mar 202310:26 amRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSTClarke - Preliminary Results
31st Jan 20237:00 amRNSNotice of Investor Presentation
26th Jan 20237:00 amRNSTrading Statement
4th Jan 202312:09 pmRNSBlock listing Interim Review
24th Nov 20227:00 amRNSTrading Statement
1st Nov 20225:13 pmRNSESOT Share Purchase
25th Oct 20222:14 pmRNSESOT Share Purchase
18th Jul 20227:00 amRNSInvestor Presentation
14th Jul 20227:00 amRNSHalf-year Report
5th Jul 202212:12 pmRNSBlock listing 6 Monthly Return
29th Jun 20227:00 amRNSNotice of Investor Presentation
23rd Jun 202210:45 amRNSNotice of Results
22nd Jun 20222:46 pmRNSChange of Auditor
22nd Jun 20229:37 amRNSTotal Voting Rights
17th May 20227:00 amRNSTClarke to Present at Mello Investor Conference

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.